Story
Nov 16, 2026
Brazil’s First Mpox Death Raises Alarm as Clade Ib Spreads
Brazil’s first mpox death of 2026 has sharpened concern over an outbreak that remains far below its 2022 peak but is increasingly concentrated in São Paulo and Rio de Janeiro. Officials are focusing on targeted vaccination and surveillance, while the growing detection of clade Ib adds urgency to that response.
Rio de Janeiro has confirmed Brazil’s first mpox death of 2026, involving a patient aged 40 to 49 who had a pre-existing immunosuppressive condition. The death comes as health authorities track an increase in reported infections and warn that people with compromised immune systems face a greater risk of severe illness.1
The immediate picture is concentrated in the country’s two largest states. Ministry of Health figures cited in reporting put São Paulo at 398 cases and Rio at 391, accounting together for about 76% of Brazil’s confirmed infections. Fiocruz data released on the same day reported slightly lower totals, a discrepancy attributed to different reporting dates or methods of consolidating records.1
Authorities in Rio have emphasized care, prevention and vaccination for groups at higher risk. The state received more than 2,000 vaccine doses, while the federal government said it had secured 25,000 additional doses for the national supply. Eligibility includes laboratory workers handling Orthopoxvirus, immunosuppressed people living with HIV, and people with medium- or high-risk direct exposure to suspected or confirmed cases. The two-dose schedule is spaced 28 days apart.2
The more pressing concern in São Paulo is clade Ib. State health officials say it represented 25% of mpox cases registered in 2026, up from less than 1% during the same period a year earlier. The variant has been associated with potentially more severe disease, although the overall national caseload remains well below the 10,591 infections recorded at the 2022 peak.1
Both accounts point to the same practical message: avoid direct contact with suspicious skin or mucosal lesions, seek medical assessment for possible symptoms, and use vaccination where indicated. Rio’s health guidance notes that lesions can occur on the face, hands, feet or genital areas, even when fever or swollen lymph nodes are absent.2